Mitsubishi UFJ Asset Management
EDIT icon

Mitsubishi UFJ Asset Management’s Editas Medicine EDIT Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-47,755
Closed -$163K – 1596
2024
Q3 		$163K Sell
47,755
-4,499
-9% -$19.6K ﹤0.01% 984
2024
Q2 		$244K Buy
52,254
+30,575
+141% +$172K ﹤0.01% 940
2024
Q1 		$161K Sell
21,679
-993
-4% -$8.25K ﹤0.01% 980
2023
Q4 		$215K Sell
22,672
-6,715
-23% -$58.9K ﹤0.01% 1002
2023
Q3 		$229K Hold
29,387
– – ﹤0.01% 1007
2023
Q2 		$242K Buy
29,387
+4,678
+19% +$40.8K ﹤0.01% 1019
2023
Q1 		$179K Buy
24,709
+1,756
+8% +$15.6K ﹤0.01% 1035
2022
Q4 		$194K Sell
22,953
-74
-0.3% -$812 ﹤0.01% 1022
2022
Q3 		$282K Buy
23,027
+367
+2% +$5.72K ﹤0.01% 986
2022
Q2 		$268K Buy
22,660
+13,721
+153% +$184K ﹤0.01% 1010
2022
Q1 		$170K Buy
8,939
+1,009
+13% +$18.8K ﹤0.01% 1078
2021
Q4 		$219K Sell
7,930
-1,295
-14% -$44.6K ﹤0.01% 1068
2021
Q3 		$379K Buy
9,225
+220
+2% +$12.1K ﹤0.01% 978
2021
Q2 		$510K Sell
9,005
-3,879
-30% -$143K ﹤0.01% 953
2021
Q1 		$541K Buy
12,884
+4,227
+49% +$241K ﹤0.01% 876
2020
Q4 		$607K Buy
8,657
+1,529
+21% +$62.8K ﹤0.01% 811
2020
Q3 		$200K Buy
7,128
+88
+1% +$2.87K ﹤0.01% 896
2020
Q2 		$208K Sell
7,040
-100
-1% -$2.61K ﹤0.01% 888
2020
Q1 		$142K Buy
7,140
+1,456
+26% +$36.7K ﹤0.01% 893
2019
Q4 		$165K Sell
5,684
-670
-11% -$16.7K ﹤0.01% 902
2019
Q3 		$144K Buy
6,354
+1,109
+21% +$27.5K ﹤0.01% 868
2019
Q2 		$130K Sell
5,245
-452
-8% -$10.8K ﹤0.01% 889
2019
Q1 		$139K Buy
5,697
+537
+10% +$12.2K ﹤0.01% 843
2018
Q4 		$113K Buy
5,160
+1,314
+34% +$35.8K ﹤0.01% 830
2018
Q3 		$122K Buy
+3,846
New +$124K ﹤0.01% 829

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mitsubishi UFJ Asset Management's EDIT Position: Q4 2024 in Review

Mitsubishi UFJ Asset Management sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 47,755 shares — an estimated $163K sold.

Mitsubishi UFJ Asset Management first reported a position in EDIT in Q3 2018 and held it in 25 quarters. The position peaked at $607K in Q4 2020. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Mitsubishi UFJ Asset Management reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 47,755 Editas Medicine shares in Q4 2024, an estimated $163K.
  • Mitsubishi UFJ Asset Management first reported a position in Editas Medicine in Q3 2018 and held it in 25 quarters.
  • Mitsubishi UFJ Asset Management's Editas Medicine position peaked at $607K in Q4 2020.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.